Potential role of macrophages in experimental keratomycosis

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2087-2094

  Hu, Jianzhang ^a   Wang, Ye ^a   Xie, Lixin ^a  

^a SHANDONG EYE INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOSOME; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; FUSARIUM SOLANI; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATOMYCOSIS; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; TISSUE HOMOGENATE; UPREGULATION; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; CANDIDIASIS; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; FUNGAL EYE INFECTION; FUSARIUM; GENETICS; IMMUNOLOGY; KERATITIS; METABOLISM; MICROBIOLOGY; MYCOSIS; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CLODRONIC ACID; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FUSARIUM; KERATITIS; LIPOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MYCOSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 65549143169     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1237     Document Type: Article

References (49)

1. Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113:1943-1948.
2. Sun XG, Zhang Y, Li Y, et al. Etiological analysis on ocular fungal infection in the period of 1989-2000. Chin Med J (Engl). 2004; 117:598-600.
3. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
4. Chowdhary A, Singh K. Spectrum of fungal keratitis in north India. Cornea. 2005;24:8-15.
5. Harris DJ Jr, Stulting RD, Waring GO 3rd, Wilson LA. Late bacterial and fungal keratitis after corneal transplantation: spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology. 1988;95:1450-1457.
6. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000; 19:307-312.
7. Wu TG, Keasler VV, Mitchell BM, Wilhelmus KR. Immunosuppression affects the severity of experimental Fusarium solani keratitis. J Infect Dis. 2004;190:192-198.
8. Kiryu H, Yoshida S, Suenaga Y, Asahi M. Invasion and survival of Fusarium solani in the dexamethasone-treated cornea of rabbits. J Med Vet Mycol. 1991;29:395-406.
9. Vemuganti GK, Garg P, Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology. 2002;109:1538-1546.
10. Dong X, Shi W, Zeng Q, Xie L. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea. Curr Eye Res. 2005;30:613-620.
11. Kende M. Role of macrophages in the expression of immune responses. J Am Vet Med Assoc. 1982;181:1037-1042.
12. Stafford JL, Neumann NF, Belosevic M. Macrophage-mediated innate host defense against protozoan parasites. Crit Rev Microbiol. 2002;28:187-248.
13. van Rooijen N, Sanders A. Elimination, blocking, and activation of macrophages: three of a kind? J Leukoc Biol. 1997;62:702-709.
14. Mendez C, Garcia I, Maier RV. Antioxidants attenuate endotoxin-induced activation of alveolar macrophages. Surgery. 1995;118: 412-420.
15. Tachado SD, Zhang J, Zhu J, et al. Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2. J Leukoc Biol. 2007;81:205-211.
16. Hayakawa M, Ghosn EE, da Gloria Teixeria de Sousa M, Ferreira KS, Almeida SR. Phagocytosis, production of nitric oxide and proinflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis. Scand J Immunol. 2006;64:382-387.
17. Levitz SM, Selsted ME, Ganz T, et al. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis. 1986;154:483-489.
18. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun. 1994;62:4755-4761.
19. Matsuda A, Tagawa Y, Matsuda H, et al. Expression of macrophage migration inhibitory factor in corneal wound healing in rats. Invest Ophthalmol Vis Sci. 1997;38:1555-1562.
20. Van Klink F, Taylor WM, Alizadeh H, Jager MJ, Van Rooijen N, Niederkorn JY. The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1996;37:1271-1281.
21. Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res. 2000;20:45-53.
22. Cheng H, Tumpey TM, Staats HF, van Rooijen N, Oakes JE, Lausch RN. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci. 2000; 41:1402-1409.
23. Bauer D, Schmitz A, van Rooijen N, et al. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology. 2002;107:118-128.
24. Hanselmayer H, Roll P. Light-and electron-microscopic examinations of deep keratomycosis (aspergillosis) (author's translation). Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978;206:203-216.
25. Ishida N, Brown AC, Rao GN, et al. Recurrent Fusarium keratomycosis: a light and electron microscopic study. Ann Ophthalmol. 1984; 16: 354-356, 358-360, 362-366.
26. Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science. 2003;300:1524-1525.
27. Heldwein KA, Liang MD, Andresen TK, et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol. 2003;74:277-286.
28. Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun. 2001;69:2402-2406.
29. van Rooijen N. The liposome-mediated macrophage "suicide" technique. J Immunol Methods. 1989;124:1-6.
30. Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci. 2003;44:210-216.
31. de Repentigny L, Petitbois S, Boushira M, et al. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun. 1993;61:3791-3802.
32. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis. 1984;150:752-760.
33. Kurup VP. Interaction of Aspergillus fumigatus spores and pulmonary alveolar macrophages of rabbits. Immunobiology. 1984; 166:53-61.
34. Kernacki KA, Goebel DJ, Poosch MS. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect Immun. 1998;66:376-379.
35. Schaller M, Boeld U, Oberbauer S, et al. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology. 2004;150:2807-2813.
36. Bonnett CR, Cornish EJ, Harmsen AG, et al. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun. 2006;74: 6528-6539.
37. Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 1995; 3:237-240.
38. Lavigne LM, Schopf LR, Chung CL, et al. The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. J Immunol. 1998;160:284-292.
39. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)-and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis. 1995;171:1279-1288.
40. Kamada N, Hisamatsu T, Okamoto S, et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol. 2005;175:6900-6908.
41. Yap G, Pesin M, Sher A. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol. 2000;165:628-631.
42. Wolf SF, Sieburth D, Sypek J. Interleukin 12: a key modulator of immune function. Stem Cells. 1994;12:154-168.
43. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133-146.
44. Denis M, Wedlock DN, Buddle BM. IFN-gamma enhances bovine macrophage responsiveness to Mycobacterium bovis: impact on bacterial replication, cytokine release and macrophage apoptosis. Immunol Cell Biol. 2005;83:643-650.
45. Hino R, Shimauchi T, Tokura Y. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides. J Dermatol Sci. 2005;38:189-195.
46. Navarathna DH, Nickerson KW, Duhamel GE, et al. Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model. Infect Immun. 2007; 75:4006-4011.
47. Romani L, Mencacci A, Tonnetti L, et al. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol. 1994;153:5167-5175.
48. Huang X, Du W, McClellan SA, et al. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2006;47:4910-4916.
49. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.